A Year After It Wins Ratiopharm, Teva Reaps Rewards in Europe

For innovator firms, Europe has been about surviving multiple price cuts and government austerity measures. For generics firms, it has become a land of opportunity, where 2011 growth will outpace the overall pharmaceutical market.